Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Involvement of GTA protein NC2beta in neuroblastoma pathogenesis suggests that it physiologically participates in the regulation of cell proliferation.
Di Pietro C, Ragusa M, Barbagallo D, Duro LR, Guglielmino MR, Majorana A, Giunta V, Rapisarda A, Tricarichi E, Miceli M, Angelica R, Grillo A, Banelli B, Defferari I, Forte S, Laganà A, Bosco C, Giugno R, Pulvirenti A, Ferro A, Grzeschik KH, Di Cataldo A, Tonini GP, Romani M, Purrello M. Di Pietro C, et al. Among authors: majorana a. Mol Cancer. 2008 Jun 6;7:52. doi: 10.1186/1476-4598-7-52. Mol Cancer. 2008. PMID: 18538002 Free PMC article.
MIR152, MIR200B, and MIR338, human positional and functional neuroblastoma candidates, are involved in neuroblast differentiation and apoptosis.
Ragusa M, Majorana A, Banelli B, Barbagallo D, Statello L, Casciano I, Guglielmino MR, Duro LR, Scalia M, Magro G, Di Pietro C, Romani M, Purrello M. Ragusa M, et al. Among authors: majorana a. J Mol Med (Berl). 2010 Oct;88(10):1041-53. doi: 10.1007/s00109-010-0643-0. Epub 2010 Jun 25. J Mol Med (Berl). 2010. PMID: 20574809
Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy.
Ragusa M, Avola G, Angelica R, Barbagallo D, Guglielmino MR, Duro LR, Majorana A, Statello L, Salito L, Consoli C, Camuglia MG, Di Pietro C, Milone G, Purrello M. Ragusa M, et al. Among authors: majorana a. BMC Cancer. 2010 Jul 19;10:377. doi: 10.1186/1471-2407-10-377. BMC Cancer. 2010. PMID: 20642818 Free PMC article.
Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment.
Ragusa M, Majorana A, Statello L, Maugeri M, Salito L, Barbagallo D, Guglielmino MR, Duro LR, Angelica R, Caltabiano R, Biondi A, Di Vita M, Privitera G, Scalia M, Cappellani A, Vasquez E, Lanzafame S, Basile F, Di Pietro C, Purrello M. Ragusa M, et al. Among authors: majorana a. Mol Cancer Ther. 2010 Dec;9(12):3396-409. doi: 10.1158/1535-7163.MCT-10-0137. Epub 2010 Sep 29. Mol Cancer Ther. 2010. PMID: 20881268
Molecular profiling of human oocytes after vitrification strongly suggests that they are biologically comparable with freshly isolated gametes.
Di Pietro C, Vento M, Guglielmino MR, Borzì P, Santonocito M, Ragusa M, Barbagallo D, Duro LR, Majorana A, De Palma A, Garofalo MR, Minutolo E, Scollo P, Purrello M. Di Pietro C, et al. Among authors: majorana a. Fertil Steril. 2010 Dec;94(7):2804-7. doi: 10.1016/j.fertnstert.2010.04.060. Epub 2010 Jun 9. Fertil Steril. 2010. PMID: 20542504 Free article.
The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma.
Di Pietro C, Ragusa M, Barbagallo D, Duro LR, Guglielmino MR, Majorana A, Angelica R, Scalia M, Statello L, Salito L, Tomasello L, Pernagallo S, Valenti S, D'Agostino V, Triberio P, Tandurella I, Palumbo GA, La Cava P, Cafiso V, Bertuccio T, Santagati M, Li Destri G, Lanzafame S, Di Raimondo F, Stefani S, Mishra B, Purrello M. Di Pietro C, et al. Among authors: majorana a. BMC Med Genomics. 2009 Apr 30;2:20. doi: 10.1186/1755-8794-2-20. BMC Med Genomics. 2009. PMID: 19402918 Free PMC article.
Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors.
Ragusa M, Statello L, Maugeri M, Majorana A, Barbagallo D, Salito L, Sammito M, Santonocito M, Angelica R, Cavallaro A, Scalia M, Caltabiano R, Privitera G, Biondi A, Di Vita M, Cappellani A, Vasquez E, Lanzafame S, Tendi E, Celeste S, Di Pietro C, Basile F, Purrello M. Ragusa M, et al. Among authors: majorana a. J Mol Med (Berl). 2012 Dec;90(12):1421-38. doi: 10.1007/s00109-012-0918-8. Epub 2012 Jun 4. J Mol Med (Berl). 2012. PMID: 22660396
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
Gurizzan C, Lorini L, Paderno A, Tomasoni M, Zigliani G, Bozzola A, Ardighieri L, Battocchio S, Bignotti E, Ravaggi A, Romani C, De Cecco L, Serafini MS, Miceli R, Bardellini E, Majorana A, Piazza C, Bossi P. Gurizzan C, et al. Among authors: majorana a. BMC Cancer. 2021 May 17;21(1):561. doi: 10.1186/s12885-021-08297-3. BMC Cancer. 2021. PMID: 34001010 Free PMC article.
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders.
Lorini L, Tomasoni M, Gurizzan C, Magri C, Facchetti M, Battocchio S, Romani C, Ravanelli M, Oberti A, Bozzola A, Bardellini E, Paderno A, Mattavelli D, Lombardi D, Grammatica A, Deganello A, Facchetti F, Calza S, Majorana A, Piazza C, Bossi P. Lorini L, et al. Among authors: majorana a. Front Oncol. 2022 Apr 21;12:886404. doi: 10.3389/fonc.2022.886404. eCollection 2022. Front Oncol. 2022. PMID: 35530364 Free PMC article.
112 results